Regeneron Pharmaceuticals, Inc. (REGN)

NASDAQ: REGN · IEX Real-Time Price · USD

893.99

-7.20 (-0.80%)

At close: Apr 18, 2024, 4:00 PM

925.25

+31.26 (3.50%)

After-hours: Apr 18, 2024, 5:43 PM EDT

Regeneron Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1994
Revenue	13,117	12,173	16,072	8,497	6,558	5,146	5,872	4,860	4,104	2,820	Upgrade
Revenue Growth (YoY)	7.76%	-24.26%	89.14%	29.58%	27.44%	-12.37%	20.82%	18.44%	45.55%	33.96%	Upgrade
Cost of Revenue	1,816	1,560	2,438	1,120	765.1	417.5	397.1	299.7	392.71	205.02	Upgrade
Gross Profit	11,301	10,613	13,634	7,377	5,793	4,728	5,475	4,561	3,711	2,615	Upgrade
Selling, General & Admin	2,631	2,116	1,825	1,346	1,342	1,127	1,320	1,178	838.53	519.27	Upgrade
Research & Development	4,439	3,593	2,860	2,647	2,450	1,469	2,075	2,052	1,621	1,271	Upgrade
Other Operating Expenses	184	165.2	2.4	-192.4	-209.2	-402.3	0	0	0	0	Upgrade
Operating Expenses	7,254	5,874	4,687	3,801	3,583	2,194	3,396	3,230	2,459	1,791	Upgrade
Operating Income	4,047	4,739	8,947	3,577	2,210	2,534	2,080	1,331	1,252	823.92	Upgrade
Interest Expense / Income	73	59.4	57.3	56.9	30.2	28.2	25.1	7.2	14.24	37.37	Upgrade
Other Expense / Income	-225.2	-179.3	-436.3	-290.7	-249.5	-47.3	-24	-6.3	12.58	25.31	Upgrade
Pretax Income	4,199	4,859	9,326	3,810	2,429	2,554	2,079	1,330	1,225	761.24	Upgrade
Income Tax	245.7	520.4	1,251	297.2	313.3	109.1	880	434.3	589.04	423.11	Upgrade
Net Income	3,954	4,338	8,075	3,513	2,116	2,444	1,199	895.5	636.06	338.13	Upgrade
Net Income Growth	-8.87%	-46.28%	129.86%	66.05%	-13.44%	103.95%	33.84%	40.79%	88.11%	-18.28%	Upgrade
Shares Outstanding (Basic)	107	107	106	108	109	108	106	105	103	101	Upgrade
Shares Outstanding (Diluted)	114	114	112	115	115	115	116	116	115	113	Upgrade
Shares Change	0.18%	1.16%	-2.52%	0.44%	-0.17%	-0.95%	-0.34%	0.93%	1.60%	1.91%	Upgrade
EPS (Basic)	37.05	40.51	76.40	32.65	19.38	22.65	11.27	8.55	6.17	3.36	Upgrade
EPS (Diluted)	34.77	38.22	71.97	30.52	18.46	21.29	10.34	7.70	5.52	2.98	Upgrade
EPS Growth	-9.03%	-46.89%	135.81%	65.33%	-13.29%	105.90%	34.29%	39.49%	85.23%	-19.89%	Upgrade
Free Cash Flow	3,875	4,425	6,529	2,004	2,000	1,812	1,035	974	652.85	419.43	Upgrade
Free Cash Flow Per Share	36.32	41.31	61.77	18.62	18.32	16.79	9.73	9.30	6.33	4.17	Upgrade
Gross Margin	86.16%	87.18%	84.83%	86.82%	88.33%	91.89%	93.24%	93.83%	90.43%	92.73%	Upgrade
Operating Margin	30.85%	38.93%	55.67%	42.09%	33.70%	49.25%	35.41%	27.38%	30.51%	29.22%	Upgrade
Profit Margin	30.14%	35.64%	50.25%	41.35%	32.26%	47.50%	20.41%	18.42%	15.50%	11.99%	Upgrade
Free Cash Flow Margin	29.54%	36.35%	40.63%	23.58%	30.51%	35.21%	17.62%	20.04%	15.91%	14.88%	Upgrade
Effective Tax Rate	5.85%	10.71%	13.41%	7.80%	12.90%	4.27%	42.34%	32.66%	48.08%	55.58%	Upgrade
EBITDA	4,693	5,260	9,669	4,103	2,670	2,730	2,249	1,442	1,314	851.29	Upgrade
EBITDA Margin	35.78%	43.21%	60.16%	48.29%	40.71%	53.05%	38.30%	29.66%	32.03%	30.19%	Upgrade
Depreciation & Amortization	421	341.4	286.2	235.9	210.3	148.2	145.5	104.7	74.91	52.69	Upgrade
EBIT	4,272	4,918	9,383	3,867	2,459	2,582	2,104	1,337	1,239	798.61	Upgrade
EBIT Margin	32.57%	40.40%	58.38%	45.51%	37.50%	50.17%	35.82%	27.51%	30.20%	28.32%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).